Pre-transplant clinical and post-transplant outcomes of patients with a novel mutation in the emerin gene

30 August 2025 (17:15 - 18:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Mario Galvan Ruiz

University Hospital Dr Negrin, Las Palmas de Gran Canaria (Spain)

6 More presentations in this session

Presentation thumbnail

LMNA variants distribution and their impact on the cardiac phenotypic spectrum

Professor K. Pilichou (Padova, IT)

Abstract Slides Video

Presentation thumbnail

From genes to outcomes: the prognostic role of genetic mutations in dilated cardiomyopathy

Doctor I. Miranda (Amadora, PT)

Abstract Slides Video

Presentation thumbnail

Refining genetic prediction in dilated cardiomyopathy: evaluating the Madrid Score and enhanced machine learning models with clinical and imaging data

Doctor I. Miranda (Amadora, PT)

Abstract Slides Video

Presentation thumbnail

Genotype-phenotype correlations with late gadolinium enhancement patterns in primary cardiomyopathy

Doctor M. Lima (Lisbon, PT)

Abstract Slides Video

Presentation thumbnail

Microstructural disease and hypoperfusion in dilated cardiomyopathy associate with ventricular arrhythmias and underpin midwall septal fibrosis

Doctor F. Chan (London, GB)

Abstract Slides

Access the full session

Session thumbnail

Precision medicine in dilated cardiomyopathy

The Event

Event poster

ESC Congress 2025

30 August 2025 17:15 CET

You may be interested in

Congress Presentation

Pre-transplant clinical and epidemiological characterization of patients with advanced heart failure and a novel mutation in the emerin gene

Congress Presentation

100 heart transplants in Canary Islands. Prevalence and distribution of family cardiomyopathies in our population

Congress Session

Improved understanding of the genetic background of cardiomyopathy

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources